Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$73.30K$73.30Kderived−80.1% vs Q4 2014 Net Income$5.38K$5.38KderivedN/M vs Q4 2014 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$696,150— Operating Cash Flowderived$552,391+739.8% Margins · derivedOperating margin-949.8%
Net margin7.3%+552.7 pt vs Q4 2014
ended Dec 31, 2015 · filed Apr 14, 2016 · 105 d after period end